Nishizawa Y - Search Results

1

Serum levels of TRAP5b, a new bone resorption marker unaffected by renal dysfunction, as a useful marker of cortical bone loss in hemodialysis patients.

Shidara K, Inaba M, Okuno S, Yamada S, Kumeda Y, Imanishi Y, Yamakawa T, Ishimura E, Nishizawa Y. Shidara K, et al. Among authors: nishizawa y. Calcif Tissue Int. 2008 Apr;82(4):278-87. doi: 10.1007/s00223-008-9127-4. Epub 2008 Apr 18. Calcif Tissue Int. 2008. PMID: 18421493

2

Impaired secretion of parathyroid hormone, but not refractoriness of osteoblast, is a major mechanism of low bone turnover in hemodialyzed patients with diabetes mellitus.

Inaba M, Nagasue K, Okuno S, Ueda M, Kumeda Y, Imanishi Y, Shoji T, Ishimura E, Ohta T, Nakatani T, Kim M, Nishizawa Y. Inaba M, et al. Among authors: nishizawa y. Am J Kidney Dis. 2002 Jun;39(6):1261-9. doi: 10.1053/ajkd.2002.33400. Am J Kidney Dis. 2002. PMID: 12046040

3

Clinical usefulness of the serum N-terminal propeptide of type I collagen as a marker of bone formation in hemodialysis patients.

Ueda M, Inaba M, Okuno S, Nagasue K, Kitatani K, Ishimura E, Shimizu M, Miki T, Kim M, Nishizawa Y. Ueda M, et al. Among authors: nishizawa y. Am J Kidney Dis. 2002 Oct;40(4):802-9. doi: 10.1053/ajkd.2002.35692. Am J Kidney Dis. 2002. PMID: 12324916

4

Body fat mass in hemodialysis patients.

Ishimura E, Okuno S, Marukawa T, Katoh Y, Hiranaka T, Yamakawa T, Morii H, Kim M, Matsumoto N, Shoji T, Inaba M, Nakatani T, Nishizawa Y. Ishimura E, et al. Among authors: nishizawa y. Am J Kidney Dis. 2003 Mar;41(3 Suppl 1):S137-41. doi: 10.1053/ajkd.2003.50103. Am J Kidney Dis. 2003. PMID: 12612971

5

FGF-23 in patients with end-stage renal disease on hemodialysis.

Imanishi Y, Inaba M, Nakatsuka K, Nagasue K, Okuno S, Yoshihara A, Miura M, Miyauchi A, Kobayashi K, Miki T, Shoji T, Ishimura E, Nishizawa Y. Imanishi Y, et al. Among authors: nishizawa y. Kidney Int. 2004 May;65(5):1943-6. doi: 10.1111/j.1523-1755.2004.00604.x. Kidney Int. 2004. PMID: 15086938 Free article.

6

Serum levels of C-terminal telopeptide of type I collagen: a useful new marker of cortical bone loss in hemodialysis patients.

Okuno S, Inaba M, Kitatani K, Ishimura E, Yamakawa T, Nishizawa Y. Okuno S, et al. Among authors: nishizawa y. Osteoporos Int. 2005 May;16(5):501-9. doi: 10.1007/s00198-004-1712-4. Epub 2004 Aug 11. Osteoporos Int. 2005. PMID: 15309383

7

Significance of Bio-intact PTH(1-84) assay in hemodialysis patients.

Inaba M, Okuno S, Imanishi Y, Ueda M, Yamakawa T, Ishimura E, Nishizawa Y. Inaba M, et al. Among authors: nishizawa y. Osteoporos Int. 2005 May;16(5):517-25. doi: 10.1007/s00198-004-1715-1. Epub 2004 Aug 20. Osteoporos Int. 2005. PMID: 15322741

8

[Metabolic bone disease and bone quality].

Yamada S, Inaba M, Nishizawa Y. Yamada S, et al. Among authors: nishizawa y. Clin Calcium. 2004 Apr;14(4):573-9. Clin Calcium. 2004. PMID: 15577013 Review. Japanese.

9

C-reactive protein is a significant predictor of decrease in fat mass in hemodialysis patients.

Fujino Y, Ishimura E, Okuno S, Tsuboniwa N, Maekawa K, Izumotani T, Yamakawa T, Inaba M, Nishizawa Y. Fujino Y, et al. Among authors: nishizawa y. Biomed Pharmacother. 2005 Jun;59(5):264-8. doi: 10.1016/j.biopha.2005.04.002. Biomed Pharmacother. 2005. PMID: 15896945

10

Serum BAP as the clinically useful marker for predicting BMD reduction in diabetic hemodialysis patients with low PTH.

Ueda M, Inaba M, Okuno S, Maeno Y, Ishimura E, Yamakawa T, Nishizawa Y. Ueda M, et al. Among authors: nishizawa y. Life Sci. 2005 Jul 22;77(10):1130-9. doi: 10.1016/j.lfs.2005.02.007. Life Sci. 2005. PMID: 15978265

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,357 results

Search Page

Filters